Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A.

Repessé, Yohann; Costa, Catherine; Palla, Roberta; Moshai, Elika Farrokhi; Borel-Derlon, Annie; D'Oiron, Roseline; Rothschild, Chantal; El-Beshlawy, Amal; Elalfy, Mohsen; Ramanan, Vijay; Eshghi, Peyman; Oldenburg, Johannes; Pavlova, Anna; Rosendaal, Frits R; Peyvandi, Flora; Kaveri, Srinivas V; Lacroix-Desmazes, Sébastien

Repessé, Yohann; Costa, Catherine; Palla, Roberta; Moshai, Elika Farrokhi; Borel-Derlon, Annie; D'Oiron, Roseline; Rothschild, Chantal; El-Beshlawy, Amal; Elalfy, Mohsen; Ramanan, Vijay; Eshghi, Peyman; Oldenburg, Johannes; Pavlova, Anna; Rosendaal, Frits R; Peyvandi, Flora; Kaveri, Srinivas V; Lacroix-Desmazes, Sébastien.

Affiliation

Repessé Y; CHU de Caen, Hematology Laboratory, Caen, France.
Costa C; INSERM, U1237, GIP Cyceron, Caen, France.
Palla R; Normandie Université, UNI-CAEN, UFR Santé, Caen, France.
Moshai EF; Service de Génétique et Biologie Moléculaires, APHP, Groupe Hospitalier Cochin Broca, Hôtel-Dieu, Site Cochin, Paris, France.
Borel-Derlon A; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milano, Italy.
D'Oiron R; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, USPC, Université Paris Descartes, Université Paris Diderot, Paris, France.
Rothschild C; CHU de Caen, Hematology Laboratory, Caen, France.
El-Beshlawy A; INSERM, U1237, GIP Cyceron, Caen, France.
Elalfy M; Normandie Université, UNI-CAEN, UFR Santé, Caen, France.
Ramanan V; Centres de Traitement de l'Hémophilie, APHP, Le Kremlin-Bicêtre, France.
Eshghi P; Centres de Traitement de l'Hémophilie, APHP, Hôpital Necker, Paris, France.
Oldenburg J; Pediatric Hematology Department, Cairo University Pediatric Hospital, Cairo, Egypt.
Pavlova A; Faculty of Medicine, Ain Shams Center, University - Department of Pediatrics, Cairo, Egypt.
Rosendaal FR; Jehangir Clinical Development Center, Department of Hematology, Jehangir Hospital Premises, Pune, India.
Peyvandi F; Pediatric Congenital Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Kaveri SV; Institute of Experimental Hematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany.
Lacroix-Desmazes S; Institute of Experimental Hematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany.

Haematologica ; 104(8): e369-e372, 2019 08.

Article de En | MEDLINE | ID: mdl-30705098

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Facteur VIII / Facteur de von Willebrand / Hémophilie A / Alloanticorps Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Haematologica Année: 2019 Type de document: Article Pays d'affiliation: France

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google